‘Text/HTML’ of page ‘NRG-LU008: LA, Inoperable NSCLC’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-LU008: LA, Inoperable NSCLC
‘Text/HTML’ of page ‘NRG-LU008: LA, Inoperable NSCLC’
Am I eligible for this study? If you over the age of 18 years with non-small cell lung cancer that has spread to lymph nodes in the chest and cannot be treated with surgery, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer […]
Read More‘Text/HTML’ of page ‘NRG-LU008: LA, Inoperable NSCLC’
About This Study NRG-LU008 is a clinical study for people with non-small cell lung cancer (NSCLC) that has spread to the lymph nodes in the chest and is not able to be treated by surgery. Typically, people with NSCLC are treated with radiation therapy and chemotherapy, followed by the immune therapy drug ‘durvalumab;’ however, […]
Read More‘Text/HTML’ of page ‘NRG-LU008: LA, Inoperable NSCLC’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-LU008: LA, Inoperable NSCLC’
The NRG-LU008 Study FAQ
Read More